Results 26 - 50 from 66 for "antibiotice iasi"
-
Antibiotice Iasi Revenue Up 47% YoY To RON361.7M In Jan-Sept 2022
11.11.2022
Romanian pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) said in a stock market report on Friday that it ended the first nine months of 2022 with sales revenue of RON361.7 million, up 47% on the more
-
Antibiotice Iasi Plans to Invest RON300M in Coming Years
10.06.2022
Romanian drug maker Antibiotice Iasi has budgeted RON300 million investments for the following years. more
-
Antibiotice Iasi Net Profit Spikes 114% YoY To RON8.6M In 1Q/2022
05.13.2022
Antibiotice Iasi (ATB.RO), the biggest Romanian-held drug maker, reported a net profit net of RON8.6 million for the first three months of 2022, up 113.7% from the year-earlier period, in line with more
-
Antibiotice Iasi Eyes RON448M Revenues and RON32M Net Profit in 2022
01.31.2022
Antibiotice Iasi (ATB.RO), the biggest local Romanian-held drug producer, projects total revenues worth RON448 million in 2022, up 15% on the year and net profit of RON32 million, 6% higher than in more
-
Antibiotice Iasi Wants 60% of Sales to Come From Abroad by 2028
12.10.2021
Antibiotice Iasi, the biggest local Romanian-held drug maker, aims for exports to weigh 50%-60% in turnover by 2028. more
-
Antibiotice Iasi Turnover Up 10% To RON161M, Net Profit Up Nearly 1% To RON19.3M In 1H/2021
07.26.2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, reported sales of RON161.4 million in the first half of 2021, up 10.2% from the same period in 2020, per calculations by more
-
Antibiotice Iasi 1Q Sales Drop 10% To RON66M, Net Profit Of RON4.03M, Close To Level In Year-Earlier Period
05.12.2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, on Wednesday reported sales of RON66.1 million for the first quarter of 2021, down 10.2% on the year, and a net profit of more
-
Antibiotice Iasi Shareholders Approve RON2.22M Dividends From 2020 Profit, At 0.6% Yield
04.21.2021
Shareholders of state-run Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Wednesday approved the distribution of dividends worth RON2.2 million from the 2020 profit, more
-
SIF Oltenia Reaches 23% Ownership In Antibiotice Iasi
04.14.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, said in a stock market report on Wednesday that regional investment fund SIF Oltenia (SIF5.RO) reached more
-
Antibiotice Iasi Investments Double YoY To RON14M In 2020
03.24.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has invested RON14 million in new product research and equipment in 2020, double compared with 2019, per more
-
Antibiotice Iasi Seeks to Distribute RON2.2M as Dividends
03.18.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, plans to distribute RON2.2 million as dividends from its 2020 profit of RON26 million profit. more
-
Antibiotice Iasi Net Profit Drops 16% in 2002, to RON25M
02.25.2021
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Thursday reported a 16% drop in net profit in 2002, to RON25 million. more
-
Antibiotice Iasi Enters US and UK Markets with Covid-19 Medication
07.09.2020
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has entered the US and UK markets with new medicines for Covid-19 by attending and winning tenders in the US and UK. more
-
Antibiotice Iasi Extends CEO's Mandate For Four Years
05.20.2020
-
Antibiotice Iasi Approves RON20M Dividends: 5.6% Yield
04.09.2020
-
Antibiotice Iasi Net Profit Declines 10% in 2019, to RON30.8M
02.27.2020
State-owned Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, said Thursday its net profit declined 10% in 2019, to RON30.8 million, while sales revenue grew 6.8%, to more
-
Antibiotice Iasi Posts RON242M Sales, RON21.5M Net Profit In Jan-Sept 2019
11.15.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Friday said it ended the first nine months of 2019 with sales revenue of RON242 million, comparable with the result reported more
-
Antibiotice Iasi Plans To Register Over 25 Products In Vietnam
10.08.2019
Antibiotice Iasi, one of the leading players in the local pharmaceuticals industry and the main producer of the active substance nystatin globally, plans to register in Vietnam over 25 products in more
-
Antibiotice Iasi To Start Payment Of RON6.7M Dividends As Of Sept 20
09.06.2019
-
Antibiotice Iasi Posts Higher Sales, Profit in 1H/2019
08.08.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Thursday reported total sales of RON172.3 million in the first half of the year, up 9%, and a net profit of RON22.3 million, more
-
Antibiotice Iasi 9-Month Sales Up 3% On Year To RON241M
11.14.2018
-
Antibiotice Iasi To Pay Out RON17.8M Worth Of Dividends, At 5% Yield
04.26.2018
-
Antibiotice Iasi Sales Revenue Up 3%, Net Profit Up 14% In First 9 Months Of 2017
11.15.2017
-
Antibiotice Iasi GM: Romania Has Europe's Lowest Drug Prices And World's Highest Clawback Tax
09.13.2017
-
Antibiotice Iasi 1Q Profit Down 26% To RON5.3M, Turnover Up 1% To RON55.4M
05.15.2017